Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 3/20 | 0.52 |
| ▸ | RAB9A | P51151 | 3/20 | 0.52 |
| ▸ | POLB | P06746 | 2/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | NPY5R | Q15761 | 2/20 | 0.42 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.42 |
| ▸ | BTK | Q06187 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 3/20 | 0.41 |
| ▸ | MTOR | P42345 | 1/20 | 0.39 |
| ▸ | ADK | P55263 | 1/20 | 0.39 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.39 |
| ▸ | DCUN1D1 | Q96GG9 | 2/20 | 0.38 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.38 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.38 |
| ▸ | PIN1 | Q13526 | 2/20 | 0.37 |
| ▸ | TNKS | O95271 | 1/20 | 0.37 |
| ▸ | PARP1 | P09874 | 1/20 | 0.37 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12716533 | 0.84 | NPC1 (0.37) | NPC1RAB9APOLBL3MBTL1SCN2A | |
| SCHEMBL384952 | 0.83 | NPC1 (0.61) | NPC1RAB9APOLBL3MBTL1NPY5R | |
| SCHEMBL24317555 | 0.80 | NPC1 (0.59) | NPC1RAB9APOLBL3MBTL1NPY5R | |
| SCHEMBL912607 | 0.80 | MAPT (0.42) | NPC1RAB9ANPY5RGAAALDH1A1 | |
| SCHEMBL14424582 | 0.78 | NISCH (0.42) | NPC1RAB9APOLBL3MBTL1NISCH | |
| SCHEMBL3987498 | 0.78 | MAPT (0.43) | NPC1RAB9APOLBGAATNKS | |
| SCHEMBL17541733 | 0.78 | NPC1 (0.42) | NPC1RAB9APOLBGAATNKS | |
| SCHEMBL31429116 | 0.78 | MAPK13 (0.40) | MAPK1NR1H2NR1H3TNKSPARP1 | |
| SCHEMBL5638065 | 0.78 | KDM4E (0.41) | NPC1RAB9APOLBSCN2AGAA | |
| SCHEMBL17948203 | 0.78 | NPC1 (0.57) | NPC1RAB9APOLBL3MBTL1NPY5R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 91 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260107722-A1 | TOOLS FOR CHEMICAL PLANARIZATION | CHEMPOWER CORP (US) | 2026-04-16 | — | — | US | disclosed |
| US-12593637-B2 | Chemical planarization | CHEMPOWER CORPORATION (US) | 2026-03-31 | — | — | US | disclosed |
| US-20260061548-A1 | PAD SURFACE REGENERATION AND METAL RECOVERY | CHEMPOWER CORP (US) | 2026-03-05 | — | — | US | disclosed |
| CN-121586633-A | Pad for chemical planarization | 肯珀尔公司 | 2026-02-27 | — | — | CN | disclosed |
| US-12500088-B2 | Tools for chemical planarization | CHEMPOWER CORPORATION (US) | 2025-12-16 | — | — | US | disclosed |
| US-12466025-B2 | Pad surface regeneration and metal recovery | CHEMPOWER CORPORATION (US) | 2025-11-11 | — | — | US | disclosed |
| US-20250091176-A1 | CHEMICAL PLANARIZATION OF NON-METALLIC MATERIALS | CHEMPOWER CORPORATION | 2025-03-20 | — | — | US | disclosed |
| CN-119350258-A | Perilla alcohol-1, 2, 4-triazole thioether derivative, and preparation method and application thereof | 南宁师范大学 | 2025-01-24 | — | — | CN | disclosed |
| US-20240391050-A1 | PADS FOR CHEMICAL PLANARIZATION | CHEMPOWER CORPORATION | 2024-11-28 | — | — | US | disclosed |
| CN-118434537-A | Tool for chemical planarization | 化学动力公司 | 2024-08-02 | — | — | CN | disclosed |
| EP-1372655-A4 | CATHEPSIN CYSTEINE PROTEASE INHIBITORS | MERCK FROSST CANADA INC (CA) | 2005-10-12 | — | — | EP | disclosed |
| US-20040198982-A1 | Cathepsin cysteine protease inhibitors | MERCK CANADA INC. (CA) | 2004-10-07 | — | — | US | disclosed |
| EP-1372655-A2 | CATHEPSIN CYSTEINE PROTEASE INHIBITORS | Merck Frosst Canada & Co. (CA) | 2004-01-02 | — | — | EP | disclosed |
| WO-2002069901-A2 | CATHEPSIN CYSTEINE PROTEASE INHIBITORS | MERCK FROSST CANADA & CO. (CA) | 2002-09-12 | — | — | WO | disclosed |
| US-5939462-A | ADMINISTERING ALKOXY AND -THIOALKOXYAMIDE COMPOSITIONS TO MAMMALS TO TREAT DISORDERS SUCH AS OBESITY THAT ARE MEDIATED BY NEUROPEPTIDE Y (?NPY?) | BAYER CORPORATION (US) | 1999-08-17 | — | — | US | disclosed |
| US-RE35754-E | FOR TREATING BACTERIAL INFECTIONS | HOECHST AKTIENGESELLSCHAFT (DE) | 1998-03-24 | — | — | US | disclosed |
| US-5710146-A | ANTIBIOTICS FOR BACTERICIDES | HOECHST AKTIENGESELLSCHAFT (DE) | 1998-01-20 | — | — | US | disclosed |
| US-5089490-A | Cephem derivatives | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-02-18 | — | — | US | disclosed |
| US-4758556-A | Cephem derivatives | HOECHST AKTIENGESELLSCHAFT (DE) | 1988-07-19 | — | — | US | disclosed |
| US-4278793-A | ANTIBIOTICS, BACTERICIDES | HOECHST AKTIENGESELLSCHAFT (DE) | 1981-07-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040198982-A1 | Cathepsin cysteine protease inhibitors | CTSB, CTSS, CTSZ | NPC1 287/4885RAB9A 477/4885POLB 3196/4885 |
| US-12593637-B2 | Chemical planarization | PPOX, GPX4, DUOX1 | NPC1 1741/4885RAB9A 2631/4885POLB 3784/4885 |
| US-20260107722-A1 | TOOLS FOR CHEMICAL PLANARIZATION | FZD7, PIEZO1, CDH1 | NPC1 1658/4885RAB9A 3527/4885POLB 4149/4885 |
| US-20260061548-A1 | PAD SURFACE REGENERATION AND METAL RECOVERY | PADI4, PADI2, PADI1 | NPC1 2888/4885RAB9A 2674/4885POLB 2039/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.